Funding for this research was provided by:
Royal Perth Hospital Medical Research Foundation (fellowship to TAS)
Motor Neurone Disease Association (Buchman/Apr13/6096, Shelkovnikova/Oct17/968-799)
Received: 12 December 2018
Accepted: 7 January 2019
First Online: 14 January 2019
Ethics approval and consent to participate
: Human samples were from clinically and histopathologically characterised ALS cases and neurologically healthy individuals. Samples were provided by the Sheffield Brain Tissue Bank and MRC London Neurodegenerative Diseases Brain Bank (Institute of Psychiatry, King’s College London). Consent was obtained from all subjects for autopsy and histopathological assessment, and research were performed in accordance with local and national Ethics Committee approved donation.
: Not applicable.
: Authors declare no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.